Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Schuschel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|May 16, 2020
RNA-Binding Proteins in Acute LeukemiasKonstantin Schuschel, Matthias Helwig, Stefan Hüttelmaier, et al.
Leukemia|February 24, 2023
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemiaHasan Issa, Laura E Swart, Milad Rasouli, et al.
International Journal of Molecular Sciences|June 27, 2020
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNAAndreas Kloetgen, Sujitha Duggimpudi, Konstantin Schuschel, et al.
Iscience|September 28, 2023
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus <i>MYNRL15</i>Michelle Ng, Lonneke Verboon, Hasan Issa, et al.
Blood|September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisOriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Blood|October 21, 2025
CPX-351 in Down syndrome-associated Myeloid Leukemia: Results and Prognostic Factors from the Phase 3 ML-DS 2018 TrialStephanie Laszig, Antonia Diederichs, Emilia Salzmann-Manrique, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Nature Communications|April 23, 2026
Single cell transcriptional evolution of myeloid leukemia of Down syndromeMi K Trinh, Konstantin Schuschel, Hasan Issa, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|May 16, 2020
RNA-Binding Proteins in Acute LeukemiasKonstantin Schuschel, Matthias Helwig, Stefan Hüttelmaier, et al.
Leukemia|February 24, 2023
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemiaHasan Issa, Laura E Swart, Milad Rasouli, et al.
International Journal of Molecular Sciences|June 27, 2020
YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNAAndreas Kloetgen, Sujitha Duggimpudi, Konstantin Schuschel, et al.
Iscience|September 28, 2023
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus <i>MYNRL15</i>Michelle Ng, Lonneke Verboon, Hasan Issa, et al.
Blood|September 27, 2021
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisOriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, et al.
Blood Advances|April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid LeukemiaLonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Blood|October 21, 2025
CPX-351 in Down syndrome-associated Myeloid Leukemia: Results and Prognostic Factors from the Phase 3 ML-DS 2018 TrialStephanie Laszig, Antonia Diederichs, Emilia Salzmann-Manrique, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Nature Communications|April 23, 2026
Single cell transcriptional evolution of myeloid leukemia of Down syndromeMi K Trinh, Konstantin Schuschel, Hasan Issa, et al.
Pageof 1